The summary below is from the full report titled “Comparison of Rosiglitazone and Metformin for Treating HIV Lipodystrophy. A Randomized Trial.” It is in the 6 September 2005 issue of Annals of Internal Medicine (volume 143, pages 337-346). The authors are J.P.H. van Wijk, E.J.P. de Koning, M. Castro Cabezas, J. op't Roodt, J. Joven, T.J. Rabelink, and A.I. Hoepelman.
HIV Lipodystrophy: Rosiglitazone or Metformin?. Ann Intern Med. 2005;143:I–38. doi: https://doi.org/10.7326/0003-4819-143-5-200509060-00004
Download citation file:
Published: Ann Intern Med. 2005;143(5):I-38.
HIV, Infectious Disease.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use